Hera;
I would not be concerned about revenue figure at such early stage. All we want to see is more pharmacies, GPs & patients on board and growth at international level. Once you have consumer numbers on the app, there will be multiple opportunities to earn good revenue. Product has potentials, well developed and been already in the market and that's what attracts me the most at such a low MC.
Not repeating the same mistake again unlike RAP existing when brokers was selling despite understanding the potential of the products.
cheers
J
Ann: Shareholder Update Resignation of Company Secretary-MDR.AX, page-7
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 27.5¢ | $254.8K | 889.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39326 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 2917 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
